Edward J. Sitar
Overview
Edward J. Sitar received an average of $802K in total compensation, including $275K in salary, at 9 METERS BIOPHARMA from 2019 to 2021. Edward Sitar also received an average of $830K at Cancer Genetics between 2014 and 2015.
Source: SEC filings on May 13, 2022, May 12, 2021, and September 12, 2016.
Related executives
We found 12 more executives who work or worked at 9 METERS BIOPHARMA and Cancer Genetics.
John Temperato
9 METERS BIOPHARMA
Chief Executive Officer
John Roberts
Cancer Genetics
Chief Executive Officer
Yung-Ping Yeh
Cancer Genetics
Chief Information Officer
Ralf Brandt
Cancer Genetics
President, Discovery & Early Development Services
Andrew LaFrence
Cancer Genetics
Chief Financial Officer
Patrick FACP
9 METERS BIOPHARMA
Chief Medical Officer
Sandeep Laumas
9 METERS BIOPHARMA
Chief Executive Officer
Jay Madan
9 METERS BIOPHARMA